Balance Sheet Components

3 Months Ended

Mar. 31, 2020

Balance Sheet Components

Balance Sheet Components

4. Balance Sheet Components

Inventory

Inventory at March 31, 2020 and December 31, 2019 consisted of the following:

	March 31,		December 31,
(in thousands)	2020		2019
	(unaudited)
Raw Material	$	551	$	457
Work in Process		1,234		1,211
Finished Goods		919		461
Inventory	$	2,704	$	2,129

Property and Equipment

Property and equipment at March 31, 2020 and December 31, 2019 consisted of the following:

	March 31,		December 31,
(in thousands)	2020		2019
	(unaudited)
Land	$	396	$	396
Lab equipment		418		411
Clinical equipment		65		65
Software		63		63
Total property and equipment at cost		942		935
Accumulated depreciation		(235)		(225)
Property and equipment, net	$	707	$	710

Depreciation and amortization expense was $10,000 and $15,000 in the three months ended March 31, 2020 and 2019, respectively.

Intangible Assets

Intangible assets at March 31, 2020 and December 31, 2019 consisted of the following:

	March 31,		December 31,
(in thousands)	2020		2019
	(unaudited)
Developed technology	$	25,000	$	25,000
Accumulated developed technology amortization		(4,444)		(4,028)
Developed technology, net		20,556		20,972
In-process research and development		4,800		8,800
Impairment		—		(4,000)
In process research and development, net		4,800		4,800
Trademarks		300		300
Accumulated trademark amortization		(54)		(48)
Trademarks, net		246		252
Total intangible assets, net	$	25,602	$	26,024

Amortization expense was $422,000 for the three months ended March 31, 2020 and 2019.